Press release
Deep Brain Stimulation Devices Market Size, Share, Trends Analysis with Forecast to 2028
Deep Brain Stimulation Devices Market for Parkinson's Disease: IntroductionAccording to the report, the global deep brain stimulation devices market for Parkinson's disease was valued at US$ 0.85 Bn in 2020 and is projected to expand at a CAGR of 5.1% from 2021 to 2028. Parkinson's disease is one of the most common chronic and progressive neurological disorders, which is characterized by postural instability, bradykinesia, akinesia, and tremors due to loss of dopamine producing neurons in substantia nigra of the mid-brain.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1435
Increase in Government Initiatives: Key Driver
Surge in the geriatric population and rise in demand for minimally invasive surgical techniques fuel the growth of the global market. Moreover, change in preferences of patients and healthcare professionals to adopt surgical DBS devices over drug therapy is projected to fuel the expansion of the global DBS devices market in the near future. This is due to considerable side effects and loss of effectiveness of drug and other therapies. This is anticipated to drive the DBS devices market for Parkinson's disease over the next few years.
Increase in the number of neurological disorders such ischemic stroke, Alzheimer's disease, essential tremors, trauma, and Parkinson's disease (PD) is a primary factor boosting the growth of the global deep brain stimulation devices market.
Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1435
North America to Dominate Deep Brain Stimulation Devices Market for Parkinson's Disease
Based on product type, the global deep brain stimulation devices market for Parkinson's disease has been segmented into single-channel deep brain stimulator, and dual-channel deep brain stimulator. In terms of end-user, the global deep brain stimulation devices market for Parkinson's disease has been classified into hospitals, ambulatory surgical centers, neurological clinics, and others.
Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1435
The global deep brain stimulation devices market for Parkinson's disease has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period, accounting for 38.60% share by 2028. The market in the region is anticipated to reach US$ 0.48 Bn by 2028.
North America's largest market share can be attributed to increase in the number of patients undergoing surgical therapy that utilizes DBS devices for treating Parkinson's disease and surge in geriatric population. Additionally, favorable government reimbursement policies and the risk of side effects related to medication treatments are expected to fuel the growth of the market in the region.
Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1435
Major Players
Major players operating in the global deep brain stimulation devices market are Medtronic, Inc., St. Jude Medical, Inc., and Boston Scientific Corporation. These companies have commercialized several significant DBS devices in the global market such as Libra, Activa, Vercise and others. Other companies active in the market include Aleva Neurotherapeutics SA, Adaptive Neuromodulation GmbH (ANM), NeuroSigma, Inc. and NeuroPace, Inc. DBS products of these players are not yet commercially available in the market, as these are still under clinical trial. Companies focus on introducing innovative products that are easy to use for physicians as well as patients. These companies aim to make the devices more portable, affordable, efficient, and effective.
Each of these players has been profiled in the deep brain stimulation devices market for Parkinson's disease report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deep Brain Stimulation Devices Market Size, Share, Trends Analysis with Forecast to 2028 here
News-ID: 2777140 • Views: …
More Releases from Transparency Market Research
Global Monochloroacetic Acid Market Set to Reach USD 1.8 Bn by 2035, Driven by S …
The global Monochloroacetic Acid (MCA) Market is entering a new phase of growth, marked by expanding industrial applications, rising agricultural needs, and notable advancements in pharmaceutical formulations. Valued at US$ 1.1 Bn in 2024, the MCA market continues to gain momentum due to its critical role as an intermediate chemical in the manufacture of herbicides, drugs, and carboxymethyl cellulose (CMC). According to recent industry projections, the market is expected to…
Global Two-Wheeler Navigation Display Market Set to Reach USD 3.5 Bn by 2035, Ex …
The global Two-Wheeler Navigation Display Market is entering a new phase of accelerated growth driven by rapid digitalization, rising motorcycle adoption, and strong demand for advanced rider-assist technologies. According to new industry analysis, the market-valued at US$ 563.3 Mn in 2024-is projected to reach US$ 3.5 Bn by 2035, registering an impressive CAGR of 16.95% during the forecast period (2025-2035).
As two-wheelers continue to dominate mobility across Asia, Europe, and emerging…
Transparent Ceramics Market to Hit USD 8.5 Bn by 2035, Driven by 21.3% CAGR Grow …
The global transparent ceramics market is entering a period of unprecedented expansion, fueled by rising demand in aerospace, defense, consumer electronics, optics, and medical imaging. Valued at US$ 1020.0 Mn in 2024, the market is projected to climb to US$ 8.5 Bn by 2035, registering an exceptional CAGR of 21.3% between 2025 and 2035. Transparent ceramics-recognized for their remarkable optical clarity, mechanical strength, and resistance to extreme temperatures-are emerging as…
Dermatoscope Market Outlook 2035: Global Revenues to Surge from USD 1.0 Billion …
The global Dermatoscope Market is entering a period of accelerated expansion, supported by a growing global emphasis on preventive dermatology, rising skin cancer incidence, and the widespread adoption of advanced imaging technologies. Valued at US$ 1.0 Bn in 2024, the market is projected to grow at a strong CAGR of 11.2% from 2025 to 2035, eventually crossing US$ 3.3 Bn by the end of 2035. This rapid growth reflects increasing…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
